Clinical Trials Directory

Trials / Unknown

UnknownNCT02994082

Treating Smokeless Tobacco Use in Rural Veterans

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
123 (actual)
Sponsor
Mark Vander Weg · Federal
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

This is a pilot study designed in an effort to develop and improve access to effective treatments for tobacco use in rural Veterans using a tailored intervention approach. Specifically, we will evaluate a combined behavioral and pharmacological smokeless tobacco cessation which concomitantly addresses comorbid issues commonly experienced by rural tobacco users including elevated depressive symptoms, risky alcohol use, and concerns about weight gain. The objectives are to: 1. Evaluate the feasibility of an individually-tailored telephone intervention for rural smokeless tobacco users 2. Examine the impact of the intervention on treatment utilization, patient satisfaction, and smokeless tobacco cessation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTailored behavioral interventionParticipants will receive a standard six session cognitive behavioral intervention for smokeless tobacco cessation combined with supplemental treatment modules based on individual need and preferences.
BEHAVIORALBehavioral activation for elevated depressive symptomsParticipants with elevated depressive symptoms may receive this six session telephone-based behavioral activation intervention.
BEHAVIORALPost-cessation weight gain managementParticipants with concerns about gaining weight after quitting smokeless tobacco use may receive this six session telephone-based behavioral self-management intervention designed to help attenuate post-cessation weight gain.
BEHAVIORALAlcohol use risk reductionParticipants engaging in risky alcohol use may receive this six session telephone-based behavioral intervention for reducing alcohol use.
DRUGNicotine replacement therapy - transdermal nicotine patchMedication selection will be based on individual participant preferences, medical history, and contraindications.
DRUGNicotine replacement therapy - nicotine lozengeMedication selection will be based on individual participant preferences, medical history, and contraindications.
DRUGNicotine replacement therapy - nicotine gumMedication selection will be based on individual participant preferences, medical history, and contraindications.
DRUGBupropion sustained releaseMedication selection will be based on individual participant preferences, medical history, and contraindications.
DRUGVareniclineMedication selection will be based on individual participant preferences, medical history, and contraindications.
DRUGCombination nicotine replacement therapyMedication selection will be based on individual participant preferences, medical history, and contraindications. Possible combinations include nicotine patch + nicotine lozenge and nicotine patch + nicotine gum.
DRUGCombination nicotine replacement therapy + bupropionMedication selection will be based on individual participant preferences, medical history, and contraindications. Possible combinations include nicotine patch + bupropion, nicotine gum + bupropion, and nicotine lozenge + bupropion.
BEHAVIORALTobacco quit lineReferral to the Department of Veterans Affairs tobacco telephone quit line.
BEHAVIORALEducational materialsInformation regarding the VA tobacco quit line and associated treatment services, self-help materials for tobacco cessation, and information about tobacco cessation medications available in the VA,

Timeline

Start date
2016-12-01
Primary completion
2019-09-01
Completion
2020-05-01
First posted
2016-12-15
Last updated
2019-07-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02994082. Inclusion in this directory is not an endorsement.